Know how Hong Kong, Singapore, and Thailand are Handling Covid-19 Spikes, and India's Preparedness

Covid-19: Renewed Activity across Asia; India Observes Mild Increase

A noticeable uptick in Covid-19 cases has been reported across several Asian countries in recent weeks, including Hong Kong, Singapore, Thailand, and even China. This resurgence has led to increased hospitalizations in some of these regions. In contrast, India is currently experiencing what health officials describe as a "mild" increase in cases, with the situation being closely monitored and public health measures in place.

Join the Whatsapp Channel to Get News updates in english

According to reports citing health officials, India has recorded 257 cases, with preliminary information suggesting these are mostly mild and not associated with unusual severity or mortality. This stands in contrast to the sharper increases seen elsewhere. For instance, Singapore's Ministry of Health reported that the estimated number of Covid-19 cases rose to 14,200 in the week of April 27 to May 3, 2025, up from 11,100 the previous week. During this period, average daily hospitalizations in Singapore increased from 102 to 133, although average daily Intensive Care Unit (ICU) cases saw a slight decrease. Singaporean hospitals are reportedly managing the current caseload effectively.

Thailand also witnessed a significant spike, with 33,030 cases reported between May 11 and May 17, including at least 6,000 cases in Bangkok, as per the Department of Disease Control. This increase in Thailand is partly attributed to the XEC variant, a strain of Omicron, and may have been influenced by increased social interactions during the Songkran holiday period in mid-April. Similarly, Hong Kong saw its Covid-19 positivity rate climb from 6.21% to 13.66% over four weeks (April 6 to April 12). Dr. Edwin Tsui, Controller of Hong Kong's Centre for Health Protection (CHP), noted that Hong Kong has experienced cycles of active Covid-19 periods every six to nine months following the resumption of normalcy. Data from the Chinese Center for Disease Control and Prevention also indicated a rise in the positivity rate among patients with flu-like symptoms visiting clinics and those admitted to hospitals between March 31 and May 4.

Factors Contributing to the Asian Surge

Health authorities in the affected regions attribute the current rise in Covid-19 cases to a combination of factors. A primary driver is believed to be waning immunity within the population. Protection derived from previous infections or vaccinations gradually decreases over time, making individuals more susceptible to new infections. This is particularly relevant for high-risk groups, such as individuals over the age of 65.

The emergence and spread of new Covid-19 variants also play a crucial role. Singaporean health authorities have identified LF.7 and NB.1.8, both descendants of the JN.1 variant that emerged in 2024, as the main circulating strains, accounting for over two-thirds of locally sequenced cases. It's noteworthy that the JN.1 variant is also used in the formulation of the current Covid-19 vaccine. In India, however, there has been no official confirmation regarding the widespread circulation of the JN.1 variant or its descendants.

Seasonal factors, increased social gatherings, and travel are also considered potential contributors to the surge in various countries. Hong Kong's health authorities have suggested that Covid-19 has transitioned into an endemic disease exhibiting a "periodic pattern." Dr. Tsui from the CHP stated that these active periods are associated with changes in predominant circulating strains and declining herd immunity in Hong Kong. Furthermore, observations from Singapore indicate that many individuals currently seeking treatment for Covid-19 symptoms had not received a booster shot in over a year, a trend that might be mirrored in other affected nations.

India's Current Situation and Response

Despite the concerning trends in some neighboring countries, the Covid-19 situation in India currently remains under control. The reported cases are few and predominantly mild. Indian health authorities, including the National Centre for Disease Control (NCDC), the Emergency Medical Relief (EMR) division, the Disaster Management Cell, the Indian Council of Medical Research (ICMR), and Central government hospitals, are maintaining a state of strong vigilance.

A review meeting was recently convened under the chairpersonship of the Director General of Health Services (DGHS) to assess the situation. According to sources, the Health Ministry remains "vigilant and proactive in monitoring the situation closely," ensuring that appropriate measures are in place to safeguard public health. This proactive stance is crucial in quickly identifying and responding to any potential escalation in cases or the emergence of new, more concerning variants within the country.

The experience of the past few years has highlighted the unpredictable nature of the Covid-19 virus. While the current mild uptick in India provides a degree of reassurance, continued adherence to public health advice, preparedness within the healthcare system, and ongoing genomic surveillance remain vital components of the nation's strategy to manage the virus effectively. The situation in other Asian countries serves as a reminder that the pandemic's dynamics can shift, requiring ongoing watchfulness and preparation.